FDA approves new pain pill Journavx, a non-opioid alternative to treat acute pain. Despite modest effectiveness, it shows promise in pain management.

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

The FDA approved Vertex Pharmaceuticals' Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigin ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...

Other new research this month looked at snow leopards, wolves, wildlife crossings, newly discovered species, and … scorpion ...

UCSF Benioff Children's Hospitals' Stad Center for Pediatric Pain, Palliative and Integrative Medicine today celebrated the opening of a first-of-its kind healthcare center according to Candy Stripe, ...

A recent study shows that the lack of trust is justified. Your doctor may be ignoring your pain. Here’s what you need to know ...